Tempo

CAT:
804-HY-W001187-01
Size:
10 mM - 1 mL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tempo - image 1

Tempo

  • Description :

    Tempo is a nitric oxide radical and a selective scavenger of ROS in mitochondria. Tempo is also an organocatalyst that disproportionates superoxide and oxidizes primary alcohols to aldehydes in a catalytic cycle. Tempo has mutagenic and antioxidant effects and can induceDNA strand breaks. Tempo also exerts cytotoxic and mutagenic properties in mouse lymphoma cells[1][2][3][4].
  • UNSPSC :

    12352005
  • Hazard Statement :

    H314, H412
  • Target :

    DNA/RNA Synthesis; Mitochondrial Metabolism; Reactive Oxygen Species (ROS)
  • Type :

    Reference compound
  • Related Pathways :

    Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
  • Applications :

    Cancer-Kinase/protease
  • Field of Research :

    Cancer
  • Assay Protocol :

    https://www.medchemexpress.com/tempo.html
  • Purity :

    99.92
  • Solubility :

    DMSO : 100 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles :

    [O]N1C(C)(C)CCCC1(C)C
  • Molecular Formula :

    C9H18NO
  • Molecular Weight :

    156.25
  • Precautions :

    H314, H412
  • References & Citations :

    [1]Chen X, et al. Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling. Br J Cancer. 2020 May 5.|[2]Kaur G, et al. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol Carcinog. 2010 Mar;49 (3) :290-301.|[3]Guo X, et al. Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells. Toxicol Sci. 2018 May 1;163 (1) :214-225.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    No Development Reported
  • CAS Number :

    [2564-83-2]